TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial

• Main Authors: Irene L. M. Klaassen (Author), Mandy N. Lauw (Author), Marianne D. van de Wetering (Author), Bart J. Biemond (Author), Saskia Middeldorp (Author), Floor C. H. Abbink (Author), Marc Bierings (Author), D. Maroeska M. W. te Loo (Author), Rob Pieters (Author), Inge M. van der Sluis (Author), Wim J. E. Tissing (Author), C. Michel Zwaan (Author), C. Heleen van Ommen (Author)
• Format: Book
• Published: BMC, 2017-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Venous thromboembolism (VTE) is a common and severe complication during treatment of acute lymphoblastic leukemia (ALL). An important cause is the intensive use of asparaginase. Prospective cohort studies in which prophylactic low-molecular-weight heparin (LMWH) was used to preve...